enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Tissue-type plasminogen activator - Wikipedia

    en.wikipedia.org/wiki/Tissue-type_plasminogen...

    Once in the body, tPA has can cause the desired thrombolytic activity (see figure), or be inactivated and removed. In the bloodstream tPA has a half-life of 4 to 6 minutes. [39] tPA can be bound by a plasminogen activator inhibitor, resulting in inactivation of its activity. The protein is then removed from the bloodstream by the liver.

  3. Template : Medications and dosages used in hormone therapy ...

    en.wikipedia.org/wiki/Template:Medications_and...

    Template:Medications and dosages used in hormone therapy for transgender men References ^ Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG (November 2017).

  4. Alteplase - Wikipedia

    en.wikipedia.org/wiki/Alteplase

    Alteplase, sold under the brand name Activase among others, is a biosynthetic form of human tissue-type plasminogen activator (t-PA). It is a thrombolytic medication used to treat acute ischemic stroke, acute ST-elevation myocardial infarction (a type of heart attack), pulmonary embolism associated with low blood pressure, and blocked central venous catheter. [5]

  5. Template : Estrogen dosages for menopausal hormone therapy

    en.wikipedia.org/wiki/Template:Estrogen_dosages...

    Estrogen dosages for menopausal hormone therapy; Route/form Estrogen Low Standard High Oral: Estradiol: 0.5–1 mg/day: 1–2 mg/day: 2–4 mg/day Estradiol valerate: 0.5–1 mg/day: 1–2 mg/day

  6. Plasminogen activator inhibitor-1 - Wikipedia

    en.wikipedia.org/wiki/Plasminogen_activator...

    Thus, PAI can be said to inhibit the serine proteases tPA and uPA/urokinase, and hence is an inhibitor of fibrinolysis, the physiological process that degrades blood clots. In addition, PAI-1 inhibits the activity of matrix metalloproteinases, which play a crucial role in invasion of malignant cells through the basal lamina .

  7. Template:Routes of administration, dosage forms - Wikipedia

    en.wikipedia.org/wiki/Template:Routes_of...

    To change this template's initial visibility, the |state= parameter may be used: {{Routes of administration, dosage forms | state = collapsed}} will show the template collapsed, i.e. hidden apart from its title bar. {{Routes of administration, dosage forms | state = expanded}} will show the template expanded, i.e. fully visible.

  8. Effective dose (pharmacology) - Wikipedia

    en.wikipedia.org/wiki/Effective_dose_(pharmacology)

    The median effective dose is the dose that produces a quantal effect (all or nothing) in 50% of the population that takes it (median referring to the 50% population base). [6] It is also sometimes abbreviated as the ED 50, meaning "effective dose for 50% of the population". The ED50 is commonly used as a measure of the reasonable expectancy of ...

  9. Template : Routes of administration, dosage forms/sandbox2

    en.wikipedia.org/wiki/Template:Routes_of...

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Pages for logged out editors learn more